2005
DOI: 10.2337/diabetes.54.6.1615
|View full text |Cite
|
Sign up to set email alerts
|

The Pathobiology of Diabetic Complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

62
3,692
3
219

Year Published

2006
2006
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 4,645 publications
(3,976 citation statements)
references
References 62 publications
62
3,692
3
219
Order By: Relevance
“…The development of complications is likely to be caused by the level of glycaemia over a period of many years (i.e. metabolic memory) against the backdrop of genetic disposition and other risk factors 20, 21, 22. The present study showed that HbA 1c levels were associated with incidence of microvascular and macrovascular complications, but that predictability was inversely related to diabetes duration.…”
Section: Discussionmentioning
confidence: 43%
“…The development of complications is likely to be caused by the level of glycaemia over a period of many years (i.e. metabolic memory) against the backdrop of genetic disposition and other risk factors 20, 21, 22. The present study showed that HbA 1c levels were associated with incidence of microvascular and macrovascular complications, but that predictability was inversely related to diabetes duration.…”
Section: Discussionmentioning
confidence: 43%
“…Positive energy balance, which is characterized by hyperglycemia and glycolytic metabolism, activates POMC neurons and generates significant ROS that acts as an endogenous intracellular feedback signal in POMC neurons to control activity. Consistent with this idea, hyperglycemia induces mitochondrial ROS production [48]. In negative energy balance, NPY/AgRP neurons respond to the low levels of glucose and increase neuronal firing rate [49] and potentially use fatty acids as fuel to sustain this firing.…”
Section: Mitochondrial Respiration and Oxidative Stress In The Hypothmentioning
confidence: 98%
“…CD36 also interacts with advanced glycation end products (AGE) (Ohgami, et al, 2001), which are generated in diabetes and chronic inflammatory settings such as atherosclerosis (Forbes, Soldatos, & Thomas, 2005,Brownlee, 2005,Basta, Schmidt, & De Caterina, 2004. Advanced glycation end products are protein adducts which are thought to accumulate, and thus may form a repetitive motif recognized by CD36 and other scavenger receptors.…”
Section: Cd36 Ligands and Functionsmentioning
confidence: 99%